Polymyositis developing after prolonged injections of pentazocine

J Rheumatol. 1996 Sep;23(9):1644-6.

Abstract

Pentazocine is a frequently used analgesic drug. Numerous complications have been reported in association with its use, including skin fibrosis, skin ulceration, abnormal skin pigmentation and symmetrical myopathy. Fibrous myopathy is a rare but conspicuous complication of prolonged pentazocine injection. However, inflammatory myopathy has not previously been related to this substance abuse. We describe a patient who developed polymyositis after 13 months of pentazocine injections.

Publication types

  • Case Reports

MeSH terms

  • Abdominal Pain / drug therapy
  • Analgesics, Opioid / adverse effects*
  • Analgesics, Opioid / therapeutic use
  • Humans
  • Injections, Intramuscular
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Pentazocine / adverse effects*
  • Pentazocine / therapeutic use
  • Polymyositis / chemically induced*
  • Polymyositis / diagnosis
  • Polymyositis / pathology
  • Time Factors

Substances

  • Analgesics, Opioid
  • Pentazocine